Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DoNotAge is a health-technology and longevity company focused on extending human healthspan through evidence-based nutraceuticals and diagnostic services. The company provides high-purity supplements targeting key biological pathways associated with aging, including NAD+ restoration, sirtuin activation, and senolytic clearance. Beyond product retail, DoNotAge offers biological age testing kits that utilize epigenetic clocks to provide users with data-driven insights into their aging process. The organization distinguishes itself by funding longevity research and collaborating with academic institutions to validate the efficacy of its offerings. Its mission is to democratize access to life-extending technologies that were previously only available to researchers or the wealthy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DoNotAge.